WO2026069205 - ANTIBODIES FOR CELL BASED METHOD OF DETERMINATION OF BOTULINUM TOXIN POTENCY

National phase entry is expected:
Publication Number WO/2026/069205
Publication Date 02.04.2026
International Application No. PCT/IB2025/059681
International Filing Date 25.09.2025
Title **
[English] ANTIBODIES FOR CELL BASED METHOD OF DETERMINATION OF BOTULINUM TOXIN POTENCY
[French] ANTICORPS POUR PROCÉDÉ BASÉ SUR LES CELLULES DESTINÉ À LA DÉTERMINATION DE LA PUISSANCE DE LA TOXINE BOTULIQUE
Applicants **
GALDERMA HOLDING SA
Inventors
FREDRIKSSON, Robert
GUDMUNDS, Lina
LEKHOLM, Emilia
IMANE, Hassani
LENGQUIST, Alexandra
NORDENANKAR, Karin
MUSCOLINO, Elena
SVENSSON, Julia
Priority Data
63/699,563   26.09.2024   US
Application details
Total Number of Claims/PCT *
Number of Independent Claims *
Number of Priorities *
Number of Multi-Dependent Claims *
Number of Drawings *
Pages for Publication *
Number of Pages with Drawings *
Pages of Specification *
*
Number of Office Actions *
*
International Searching Authority
*
Recordal of a Change of the Applicant's Name/Address
*
Type of Assignment
*
Applicant's Legal Status
*
*
*
*
*
*
Entry into National Phase under
*
Patent Delivery
*
译文

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country StagesTotal
China Filing, Examination, Granting3029
EPO Filing, Examination, Granting22039
Japan Filing, Examination, Granting2927
South Korea Filing, Examination, Granting3643
USA Filing, Examination, Granting9940
MasterCard Visa
Total: 41,578
Contact Us
Abstract[English] Antibodies that bind to SNAP-25 are provided. Botulinum toxin potency screening assays that utilize anti-SNAP-25 antibodies are also provided.[French] L'invention concerne des anticorps qui se lient à SNAP-25. L'invention concerne également des analyses de détermination de la puissance de la toxine botulique faisant intervenir des anticorps anti-SNAP-25.